Understanding Adult Central Nervous System Hemangioblastomas: meta-analysis of meta-analysis.

Adults Hemangioblastoma Infratentorial Spinal Supratentorial Systematic Review

Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
10 Aug 2024
Historique:
received: 03 05 2024
revised: 05 08 2024
accepted: 06 08 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 12 8 2024
Statut: aheadofprint

Résumé

Adult hemangioblastomas are rare WHO central nervous system (CNS) Grade 1 tumors particularly affecting the posterior cranial fossa. They exhibit a gender bias, impacting men in their fifth and sixth decades of life and manifesting sporadically or as part of von Hippel Lindau (VHL) disease. Understanding the intricacies of CNS hemangioblastomas is crucial for clinical decision-making. A systematic review of 576 articles was conducted following PRISMA guidelines. Eligibility criteria included 3189 adult cases of CNS hemangioblastomas. Data on patient demographics, tumor characteristics, symptoms, treatment modalities, complications, and outcomes were systematically extracted and synthesized. The review revealed a heterogeneous demographic distribution, with a male predominance. Median age at diagnosis was 44.7 years. Cranial hemangioblastomas were more commonly located in the infratentorial (73 %) than supratentorial (27%) compartments. Spinal hemangioblastomas were mostly located in the cervical spine (44.3 %), followed by thoracic (36.7 %) and lumbar spine (12 %). Clinical symptoms varied by location, emphasizing the importance of anatomical considerations. Surgical intervention-total resection (82% of cases)-was the preferred treatment modality, while radiotherapy was less common. Histological examination and immunohistochemistry aided in accurate diagnosis. Complications were location-specific, with intracranial complications more common in infratentorial tumors. Overall, favorable outcomes were prevalent (78% of cases), with low mortality rates. Adult CNS hemangioblastomas present with diverse characteristics and clinical manifestations. Surgical intervention remains the mainstay treatment; ongoing research into genetic and molecular mechanisms may enhance our understanding of tumor pathology and lead to improved management strategies in the future.

Identifiants

pubmed: 39134299
pii: S1878-8750(24)01393-7
doi: 10.1016/j.wneu.2024.08.032
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Dragan Jankovic (D)

Department of Neurosurgery, University Medical Centre of the Johannes Gutenberg University of Mainz, Mainz, Germany; Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia.

Ema Selimovic (E)

Department of Medicine, Sarajevo School of Science of Technology, Sarajevo, Bosnia and Herzegovina.

Marin Kuharic (M)

Department of Radiology, Clinical Hospital Sveti Duh, Zagreb, Croatia.

Bruno Splavski (B)

Division of Neurosurgery, Department of Surgery, Dubrovnik General Hospital, Dubrovnik, Croatia.

Kresimir Rotim (K)

Department of Neurosurgery, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia; Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia; University of Applied Health Sciences, Zagreb, Croatia.

Kenan I Arnautovic (KI)

Semmes Murphey Neurologic & Spine Institute, Memphis, Tennessee, USA; Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA. Electronic address: kenanarnaut@yahoo.com.

Classifications MeSH